EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DKK1 Promotes Cisplatin Resistance in Oral Squamous Cell Carcinoma via SLC3A2 ‐Dependent Ferroptosis Suppression

Zhuoxuan Liu iD, Xiaolan Chen iD, Yucong Lin iD, Lijun Zhu iD

Cancer Reports · 2026

DOI: 10.1002/cnr2.70715 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2026. Verfasst von Zhuoxuan Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical Univer…. Hauptthemen laut MEDLINE: Cisplatin, Drug Resistance, Neoplasm, Mouth Neoplasms, Ferroptosis. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Postdoctoral Foundation from the Ministry of Human Resources and Social Security of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oral squamous cell carcinoma (OSCC) is a prevalent malignancy associated with poor outcomes, largely attributable to cisplatin resistance—the standard chemotherapeutic agent.

Aims

While ferroptosis has been proposed as a promising therapeutic target, how it is regulated in OSCC remains largely unclear. Methods and Results To determine DKK1 expression levels and their prognostic implication, the TCGA‐HNSC cohort and OSCC patient samples were examined. The impact of DKK1 silencing and/or cisplatin treatment on cell proliferation and ferroptosis‐related markers, including reactive oxygen species (ROS), malondialdehyde (MDA), and glutathione (GSH) levels, was investigated in vitro. Additionally, the efficacy of DKK1 inhibition was evaluated in xenograft models. The findings revealed that DKK1 expression was markedly elevated in the TCGA‐HNSC cohort and was further validated in OSCC tissues. High DKK1 expression was associated with worse survival and contributed to cisplatin resistance, while DKK1 silencing sensitized cells to ferroptosis and enhanced cisplatin cytotoxicity. Mechanistically, our data support a regulatory model in which DKK1 maintains SLC3A2 expression through modulation of the β‐catenin/STAT3 axis, thereby contributing to ferroptosis suppression and cisplatin resistance. In vivo, DKK1 inhibition improved cisplatin efficacy, at least in part, by promoting SLC3A2‐associated ferroptosis.

Conclusion

These findings support DKK1 as a potential regulator of ferroptosis and cisplatin resistance in OSCC. Targeting the DKK1/SLC3A2 axis to restore ferroptotic sensitivity may represent a promising strategy to overcome chemoresistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinDrug Resistance, NeoplasmMouth NeoplasmsFerroptosisIntercellular Signaling Peptides and ProteinsSquamous Cell Carcinoma of Head and NeckHumansAnimalsMiceXenograft Model Antitumor AssaysCell Line, TumorFemaleCell ProliferationGene Expression Regulation, NeoplasticSTAT3 Transcription FactorAntineoplastic Agentsbeta CateninMale

Stichwörter der Autor:innen

DKK1SLC3A2cisplatin resistanceferroptosisoral squamous cell carcinoma

Substanzen

CisplatinIntercellular Signaling Peptides and ProteinsDKK1 protein, humanSTAT3 Transcription FactorAntineoplastic Agentsbeta Catenin

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Department of Stomatology, The Second People's Hospital of Panyu Guangzhou, Guangzhou, China.
  • Orthopedic Center, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

ORCID-Profile: Zhuoxuan Liu, Xiaolan Chen, Yucong Lin, Lijun Zhu

Förderung

  • Postdoctoral Foundation from the Ministry of Human Resources and Social Security of China

Zitieren

APA

Liu, Z., Chen, X., Lin, Y., & Zhu, L. (2026). DKK1 Promotes Cisplatin Resistance in Oral Squamous Cell Carcinoma via SLC3A2 ‐Dependent Ferroptosis Suppression. Cancer Reports. https://doi.org/10.1002/cnr2.70715

Vancouver

Liu Z, Chen X, Lin Y, Zhu L. DKK1 Promotes Cisplatin Resistance in Oral Squamous Cell Carcinoma via SLC3A2 ‐Dependent Ferroptosis Suppression. Cancer Reports. 2026. doi:10.1002/cnr2.70715

BibTeX
@article{Liu2026,
  author = {Liu, Zhuoxuan and Chen, Xiaolan and Lin, Yucong and Zhu, Lijun},
  title = {DKK1 Promotes Cisplatin Resistance in Oral Squamous Cell Carcinoma via SLC3A2 ‐Dependent Ferroptosis Suppression},
  journal = {Cancer Reports},
  year = {2026},
  doi = {10.1002/cnr2.70715}
}
Kostenlos starten →